Sylebra Capital (HK) Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elastic
ESTC
|
+$108M |
| 2 |
eHealth
EHTH
|
+$44M |
| 3 |
JOYY
JOYY Inc
JOYY
|
+$31.1M |
| 4 |
DOYU
DouYu International Holdings
DOYU
|
+$29M |
| 5 |
Pinduoduo
PDD
|
+$10.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
OPTU
Optimum Communications Inc
OPTU
|
+$80.7M |
| 2 |
COUP
Coupa Software Incorporated
COUP
|
+$22.2M |
| 3 |
Sea Limited
SE
|
+$16.6M |
| 4 |
Gaotu Techedu
GOTU
|
+$6.62M |
| 5 |
Chegg
CHGG
|
+$2.37M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 67.22% |
| 2 | Consumer Discretionary | 13.56% |
| 3 | Communication Services | 12.42% |
| 4 | Consumer Staples | 4.91% |
| 5 | Financials | 1.42% |
Similar funds
Sylebra Capital (HK)'s Q3 2019 Portfolio in Review
As of Q3 2019, Sylebra Capital (HK) held 28 positions worth $2.29B, up 6% from $2.16B the previous quarter. Its ten largest holdings account for 78% of the portfolio.
Sylebra Capital (HK) deployed $135M of net new capital in Q3 2019, opening 3 new positions and adding to 12 existing holdings. Its largest new stake was eHealth: 487,982 shares worth $32.6M.
By sector, the portfolio is most concentrated in Technology at 67% of assets, up from 67% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was Optimum Communications Inc, an estimated $80.7M trimmed.
- Sylebra Capital (HK)'s largest Q3 2019 buy was eHealth: 487,982 shares worth $32.6M.
- Sylebra Capital (HK) added most to Elastic in Q3 2019, an estimated $108M increase.
- Sylebra Capital (HK)'s biggest Q3 2019 reduction was Optimum Communications Inc, cutting an estimated $80.7M.
- Sylebra Capital (HK) fully exited Sea Limited in Q3 2019, selling an estimated $16.6M.
- Sylebra Capital (HK)'s ten largest holdings make up 78% of its $2.29B portfolio in Q3 2019.
- Sylebra Capital (HK) opened 3 new positions and closed 1 in Q3 2019.
- Sylebra Capital (HK)'s portfolio value rose 6% quarter-over-quarter to $2.29B.
Based on Sylebra Capital (HK)'s 13F filing for Q3 2019, filed 15 Nov 2019.